Low Uptake of Guideline-Recommended MRI Screening for Silent Cerebral Infarcts over the Lifespan in Sickle Cell Anemia

Silent cerebral infarcts (SCIs) are common and clinically consequential in individuals with sickle cell anemia (SCA; HbSS or HbSβ⁰-thalassemia). In 2020, the American Society of Hematology recommended magnetic resonance imaging (MRI)-based screening in childhood (strong recommendation) and adulthood (conditional recommendation); however, real-world implementation remains poorly characterized. We conducted a multicenter sequential mixed-methods study integrating site-level MRI utilization data, clinician surveys, and semi-structured interviews. Eleven academic SCD programs contributed MRI data for patients aged 5-18 years and >18 years. Clinicians completed the Clinician Guideline Determinants Questionnaire (CGDQ), adapted for pediatric and adult SCI screening, and a purposively sampled subset participated in interviews guided by the Tailored Implementation for Chronic Diseases framework. Thirty-eight clinicians completed surveys, and 25 participated in interviews. Clinicians endorsed the evidence supporting SCI screening; however, readiness to implement adult screening was lower than for pediatric screening (mean CGDQ score 117.0 vs. 126.4). Across 6,959 patients with SCA, fewer than 1 in 8 (11.75%) had undergone brain MRI over the study period (2015-2024), with consistently lower utilization in adult-only programs. Qualitative analysis identified 5 modifiable, multilevel determinants influencing implementation: unclear guideline expectations, patient and family readiness, interprofessional workflows and interpretation capacity, clinic resources and staffing infrastructure, and structural and policy barriers. Despite strong clinician support for SCI screening, implementation remains inconsistent, particularly in adult SCA care. Identified determinants highlight actionable targets for multicomponent implementation strategies to improve uptake and sustainability of MRI-based SCI screening across the lifespan.

Authors

Institutions

Publication Details

Journal
Blood Advances
Published
2026-11-17
DOI
https://doi.org/10.1182/bloodadvances.2026021489
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Low Uptake of Guideline-Recommended MRI Screening for Silent Cerebral Infarcts over the Lifespan in Sickle Cell Anemia

Grace Hurley, Deepa G. Manwani, Kaitlin L. Strumph, Lewis Li-yen Hsu et al.
Blood Advances
Hemoglobinopathies and Related Disorders
article

Low Uptake of Guideline-Recommended MRI Screening for Silent Cerebral Infarcts over the Lifespan in Sickle Cell Anemia

Grace Hurley, Deepa G. Manwani, Kaitlin L. Strumph, Lewis Li-yen Hsu, Allison A. King, Venée N. Tubman, Alexis A. Thompson, Ana A. Baumann, Lisa M. Klesges, Elizabeth S. Klings, Elfaridah P. Frazier, Ellen B. Fung, Peter Doré, Elliott P. Vichinsky, Ibrahim F. Ibrahim, Amanda M. Brandow, Aminata Niang
article en

Abstract

Silent cerebral infarcts (SCIs) are common and clinically consequential in individuals with sickle cell anemia (SCA; HbSS or HbSβ⁰-thalassemia). In 2020, the American Society of Hematology recommended magnetic resonance imaging (MRI)-based screening in childhood (strong recommendation) and adulthood (conditional recommendation); however, real-world implementation remains poorly characterized. We conducted a multicenter sequential mixed-methods study integrating site-level MRI utilization data, clinician surveys, and semi-structured interviews. Eleven academic SCD programs contributed MRI data for patients aged 5-18 years and >18 years. Clinicians completed the Clinician Guideline Determinants Questionnaire (CGDQ), adapted for pediatric and adult SCI screening, and a purposively sampled subset participated in interviews guided by the Tailored Implementation for Chronic Diseases framework. Thirty-eight clinicians completed surveys, and 25 participated in interviews. Clinicians endorsed the evidence supporting SCI screening; however, readiness to implement adult screening was lower than for pediatric screening (mean CGDQ score 117.0 vs. 126.4). Across 6,959 patients with SCA, fewer than 1 in 8 (11.75%) had undergone brain MRI over the study period (2015-2024), with consistently lower utilization in adult-only programs. Qualitative analysis identified 5 modifiable, multilevel determinants influencing implementation: unclear guideline expectations, patient and family readiness, interprofessional workflows and interpretation capacity, clinic resources and staffing infrastructure, and structural and policy barriers. Despite strong clinician support for SCI screening, implementation remains inconsistent, particularly in adult SCA care. Identified determinants highlight actionable targets for multicomponent implementation strategies to improve uptake and sustainability of MRI-based SCI screening across the lifespan.

Blood Advances
Boston University (US), St. Jude Children's Research Hospital (US), Children's Hospital of Philadelphia (US), Medical College of Wisconsin (US), Washington University in St. Louis (US), University of Illinois Chicago (US), UCSF Benioff Children's Hospital (US), Children's Hospital at Montefiore (US), The University of Texas Southwestern Medical Center (US)
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon